Evidence from Real-world Cardiometabolic Observational Studies

SUBSCRIBE HERE FOR WEEKLY UPDATES

LATEST PAPERS

Jan
19
Obstructive Sleep Apnea, a Risk Factor for Cardiovascular and Microvascular Disease in Patients With Type 2 Diabetes: Findings From a Population-Based Cohort Study
Nicola J Adderley, Anuradhaa Subramanian, Konstantinos Toulis, Krishna Gokhale, Thomas Taverner, Wasim Hanif, Shamil Haroon, G Neil Thomas, Christopher Sainsbury, Abd A Tahrani, Krishnarajah Nirantharakumar
Jan
18
The impact of diabetes, education and income on mortality and cardiovascular events in hypertensive patients: A cohort study from the Swedish Primary Care Cardiovascular Database (SPCCD)
Tobias Andersson, Miriam Pikkemaat, Linus Schiöler, Per Hjerpe, Axel C Carlsson, Per Wändell, Karin Manhem, Thomas Kahan, Jan Hasselström, Kristina Bengtsson Boström
Jan
18
Comparative Effectiveness of the Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Versus Other Antihyperglycemics on Risk of Major Adverse Kidney Events
Yan Xie, Benjamin Bowe, Andrew K Gibson, Janet B McGill, Yan Yan, Geetha Maddukuri, Ziyad Al-Aly
Jan
04
Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study
Nicklas Vinter, Qiuxi Huang, Morten Fenger-Grøn, Lars Frost, Emelia J Benjamin, and Ludovic Trinquart
Dec
18
Temporal Trend in Young-Onset Type 2 Diabetes-Macrovascular and Mortality Risk: Study of U.K. Primary Care Electronic Medical Records
Digsu N Koye, Joanna Ling, John Dibato, Kamlesh Khunti, Olga Montvida, Sanjoy K Paul

GO TO PAPERS